Power Law company profile

Prexton therapeutics

Biotech & Life Sciences · Oss, Netherlands · Founded 2012 Unicorn

Integrates molecular, behavioral and chemistry technologies to address Parkinson’s disease and other brain disorders

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

5 investors on Prexton therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Eclosion

Series A 2 investors entered at this stage

M Ventures

Ysios Capital

Series B+ 2 investors entered at this stage

Seroba Life Sciences

Forbion Capital Partners

Global footprint

Where Prexton therapeutics has talent and traffic

Workforce by country

🇳🇱 Netherlands · Oss HQ

Book a demo for the full country breakdown

Web traffic by country

1.2K monthly visits
across markets

🇧🇷 Brazil33.3%

🇮🇳 India25%

🇨🇴 Colombia16.7%

🇹🇷 Turkey8.3%

🇹🇼 Taiwan8.3%

Top 5 markets shown

Patent intelligence

$26k patent portfolio · 2 active families

Estimated portfolio value

$26k

<0.01% of valuation · 11099.3× smaller than top peer SAGE Therapeutics ($289M)

2 active patent families

Where Prexton therapeutics innovates Glutamic acidChromoneNervous systemOral administrationMedicinal chemistry

Where Prexton therapeutics concentrates vs peers

Each axis is a top-10 topic across Prexton therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Prexton therapeutics

An AI-synthesized read of the highest-engagement posts about Prexton therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prexton therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles